EPCAM and liver cancer: The EpCAM+ cells were sorted out from unfractionated fetal liver cells and liver cancer cells using FACS analysis; 2.5%±1.8% of the fetal liver cells and 5.7%±1.2% of the liver cancer cells were expressing the EpCAM receptors (Fig. 1B).